Change of mortality of patients with acute ischemic stroke before and after 2015open access
- Authors
- Park, Sang-Won; Lee, Ji Young; Heo, Nam Hun; Han, James Jisu; Lee, Eun Chae; Hong, Dong-Yong; Lee, Dong-Hun; Lee, Byung Cheol; Lim, Young Wha; Kim, Gui Ok; Lee, Man Ryul; Oh, Jae Sang
- Issue Date
- Aug-2022
- Publisher
- Frontiers Media S.A.
- Keywords
- stroke; acute ischemic stroke; mechanical thrombectomy (MT); intravenous thrombolysis (IVT); trend research; stroke care
- Citation
- Frontiers in Neurology, v.13, no.0, pp 1 - 13
- Pages
- 13
- Journal Title
- Frontiers in Neurology
- Volume
- 13
- Number
- 0
- Start Page
- 1
- End Page
- 13
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21428
- DOI
- 10.3389/fneur.2022.947992
- ISSN
- 1664-2295
- Abstract
- IntroductionAdvances in the diagnosis and management of acute ischemic stroke (AIS) and the increased use of mechanical thrombectomy (MT) have improved the quality of care and prognosis of patients with AIS since 2015. We investigated the changing trends in mortality of patients with AIS in Korea before and after 2015. Materials and methodsA retrospective cohort study was conducted using combined anonymized data from the Acute Stroke Assessment Registry of Korea and the Health Insurance Review & Assessment Service database. Patients with ischemic stroke with precise onset time and initial National Institute of Health Stroke Scale records were included. ResultsPatients receiving MT treatment increased from 256 (2.7%) pre-2015 to 1,037 (3.9%) post-2015 (p < 0.001). Overall mortality significantly decreased from pre-2015 to post-2015. In pre-2015, intravenous thrombolysis (IVT) administered within 2 h significantly reduced 3-month mortality when compared with non-IVT. While, in post-2015, IVT administered within 2 h significantly reduced the 3-month, 1-year, 2-year, and 4-year mortality (p < 0.05). MT only reduced 1-year mortality pre-2015; however, MT significantly reduced the 3-month, 1-year, and 2-year mortality post-2015 (p < 0.05). Post-stroke antiplatelet and anticoagulant drugs significantly reduced the 3-month, 1-year, 2-year, and 4-year mortality post-2015. DiscussionSince 2015, faster IVT has significantly reduced the short- and long-term mortality in patients with AIS; MT reduced the 3-month, 1-year, and 2-year mortality. Post-stroke antithrombotic medication has significantly lowered the 2- and 4-year mortality since 2015. ConclusionsChanging trends in AIS management since 2015 have improved the prognosis of patients with AIS.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Neurosurgery > 1. Journal Articles
- Graduate School > Department of Integrated Biomedical Science > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21428)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.